BUFFALO GROVE, Ill.--(BUSINESS WIRE)--Akorn, Inc. (NASDAQ:AKRX) today announced the signing of a five-year commercial manufacturing and supply agreement with a U.S. ophthalmic company. Under the terms of the five-year agreement, Akorn will be responsible for the exclusive manufacturing and supply of three OTC eye care products. The line of products will be manufactured at Akorn’s Decatur, IL production facility and are targeted for distribution in the U.S. and world wide markets.
